305 related articles for article (PubMed ID: 15968462)
21. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides.
Futaki S; Nakase I; Suzuki T; Youjun Z; Sugiura Y
Biochemistry; 2002 Jun; 41(25):7925-30. PubMed ID: 12069581
[TBL] [Abstract][Full Text] [Related]
22. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
23. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.
Wender PA; Mitchell DJ; Pattabiraman K; Pelkey ET; Steinman L; Rothbard JB
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13003-8. PubMed ID: 11087855
[TBL] [Abstract][Full Text] [Related]
24. Intracellular transduction using cell-penetrating peptides.
Sawant R; Torchilin V
Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
[TBL] [Abstract][Full Text] [Related]
25. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
Chugh A; Eudes F; Shim YS
IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo delivery of therapeutic proteins using cell penetrating peptides.
Bolhassani A; Jafarzade BS; Mardani G
Peptides; 2017 Jan; 87():50-63. PubMed ID: 27887988
[TBL] [Abstract][Full Text] [Related]
27. Novel application of polioviral capsid: development of a potent and prolonged oral calcitonin using polioviral binding ligand and Tat peptide.
Manosroi J; Lohcharoenkal W; Götz F; Werner RG; Manosroi W; Manosroi A
Drug Dev Ind Pharm; 2014 Aug; 40(8):1092-100. PubMed ID: 23802147
[TBL] [Abstract][Full Text] [Related]
28. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
29. Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).
Tréhin R; Krauss U; Muff R; Meinecke M; Beck-Sickinger AG; Merkle HP
Pharm Res; 2004 Jan; 21(1):33-42. PubMed ID: 14984255
[TBL] [Abstract][Full Text] [Related]
30. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
31. Modulation of nuclear internalization of Tat peptides by fluorescent dyes and receptor-avid peptides.
Shen D; Liang K; Ye Y; Tetteh E; Achilefu S
FEBS Lett; 2007 May; 581(9):1793-9. PubMed ID: 17416362
[TBL] [Abstract][Full Text] [Related]
32. Membrane binding and translocation of cell-penetrating peptides.
Thorén PE; Persson D; Esbjörner EK; Goksör M; Lincoln P; Nordén B
Biochemistry; 2004 Mar; 43(12):3471-89. PubMed ID: 15035618
[TBL] [Abstract][Full Text] [Related]
33. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
34. In vitro efficient transfection by CM₁₈-Tat₁₁ hybrid peptide: a new tool for gene-delivery applications.
Salomone F; Cardarelli F; Signore G; Boccardi C; Beltram F
PLoS One; 2013; 8(7):e70108. PubMed ID: 23922923
[TBL] [Abstract][Full Text] [Related]
35. Membrane Crossing and Membranotropic Activity of Cell-Penetrating Peptides: Dangerous Liaisons?
Walrant A; Cardon S; Burlina F; Sagan S
Acc Chem Res; 2017 Dec; 50(12):2968-2975. PubMed ID: 29172443
[TBL] [Abstract][Full Text] [Related]
36. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
37. [Tracking Trojan peptides in cells].
Sagan S; Burlina F; Delaroche D; Aussedat B; Aubry S; Bolbach G; Lavielle S; Chassaing G
J Soc Biol; 2006; 200(3):213-9. PubMed ID: 17417135
[TBL] [Abstract][Full Text] [Related]
38. Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways.
Ignatovich IA; Dizhe EB; Pavlotskaya AV; Akifiev BN; Burov SV; Orlov SV; Perevozchikov AP
J Biol Chem; 2003 Oct; 278(43):42625-36. PubMed ID: 12882958
[TBL] [Abstract][Full Text] [Related]
39. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.
Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E
Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and non-translocating variants with phospholipid vesicles.
Magzoub M; Eriksson LE; Gräslund A
Biophys Chem; 2003 Mar; 103(3):271-88. PubMed ID: 12727289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
